Because IL-6 can activate the NF-κB pathway to express several inflammatory-related genes, including cytokines, USP24-mediated IL-6 expression might be crucial to control the other cytokines in the tumor-associated microenvironment28. This evidence concerns the gene NFKB1 and neoplasm.